Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

about

Further study of circulating IgG antibodies to CD25-derived peptide antigens in nonsmall cell lung cancer Novel type of protein chip for multiplex detection of autoantibodies.

P2860

Q36694379-F08A4973-B472-4C37-87D9-97467DC0FF3B Q42265250-461F82F7-2D34-44AA-AE59-E66D233B5C49

P2860

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

Item

http://www.wikidata.org/entity/Q36718892

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@ast

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@en

type

Item

label

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@ast

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@en

prefLabel

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@ast

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@en

P1476

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

@en

P2093

Martin Fusek

http://www.w3.org/2001/XMLSchema#string

Vaclav Vetvicka

http://www.w3.org/2001/XMLSchema#string

P2860

Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications

Cathepsin D--many functions of one aspartic protease

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Cathepsin D in cancer metastasis: a protease and a ligand.

Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.

Autoantibody signatures: progress and perspectives for early cancer detection

Procathepsin D and cancer: From molecular biology to clinical applications.

Procathepsin D as a tumor marker, anti-cancer drug or screening agent.

Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors.

Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.5306/WJCO.V4.I1.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236090300

http://www.w3.org/2001/XMLSchema#string

P698

23538881

http://www.w3.org/2001/XMLSchema#string

P921

autoantibody

P932

3609012

http://www.w3.org/2001/XMLSchema#string

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

about

P2860

P2860

Cathepsin D: Autoantibody profiling as a diagnostic marker for cancers

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932